Combining contrast enhanced mammography and radio-active free magnetic seed localization of non-palpable breast tumors: A feasibility study

Combining contrast enhanced mammography and radio-active free magnetic seed localization of non-palpable breast tumors: A feasibility study - CEMMAG

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON56142

Enrollment

Registered

2023-03-08

Start date

2023-09-08

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer breast tumor

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women scheduled for breast conservative therapy for a non-palpable breast lesion requiring image-guided localization using a magnetic seed.

Exclusion criteria

Exclusion criteria: Unable to provide written informed consent. Age

Design outcomes

Primary

Measure	Time frame
The primary study aim will be to test whether the magnetic seeds caused any disturbing artifacts on CEM images. For this purpose, two blinded radiologists will score the images for the presence of any artifacts and if present, if these are to such an extent that they would hamper diagnostic evaluation of the images.	—

Secondary

Measure	Time frame
As secondary study, we will document technical success rate of seed deployment and retrieval during surgery, including the assessment of the surgical margins (positive or negative).	—

Countries

Netherlands

Outcome results